#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1659755	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 2 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	11		organism-based format	Scientific Literature
2.	ALA1659756	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 2 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	17		organism-based format	Scientific Literature
3.	ALA1659757	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 1 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	3		organism-based format	Scientific Literature
4.	ALA1659758	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 0.2 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	2		organism-based format	Scientific Literature
5.	ALA1659759	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.2 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	2		organism-based format	Scientific Literature
6.	ALA1659760	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 0.125 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	1		organism-based format	Scientific Literature
7.	ALA1659761	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.125 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	7		organism-based format	Scientific Literature
8.	ALA1659762	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 0.0625 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	1		organism-based format	Scientific Literature
9.	ALA1660228	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.0625 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	2		organism-based format	Scientific Literature
10.	ALA1660229	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.03125 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	1		organism-based format	Scientific Literature
11.	ALA1660230	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 1 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	2		organism-based format	Scientific Literature
12.	ALA1660231	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.5 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	21		organism-based format	Scientific Literature
13.	ALA1660232	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.25 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	9		organism-based format	Scientific Literature
14.	ALA1660233	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 0.25 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	3		organism-based format	Scientific Literature
15.	ALA1660234	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 0.20 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	1		organism-based format	Scientific Literature
16.	ALA1660235	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.20 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	1		organism-based format	Scientific Literature
17.	ALA1660236	F	Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 0.5 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days	Trypanosoma evansi	14		organism-based format	Scientific Literature
18.	ALA1099530	F	Antitrypanosomal activity against Trypanosoma evansi ITMAV170475 after 48 hrs by alamar blue assay	Trypanosoma evansi	10		organism-based format	Scientific Literature
19.	ALA4813526	F	Trypanocidal activity against Trypanosoma evansi assessed as reduction in intracellular ATP production incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay	Trypanosoma evansi	50		organism-based format	Scientific Literature
20.	ALA5044115	F	Trypanocidal activity against Trypanosoma evansi assessed as parasite growth inhibition at 50 ug/ml incubated for 3 days by Celltiter-Glo luminescence assay	Trypanosoma evansi	26		organism-based format	Scientific Literature